Einstein Experts

Search Results

You searched for "gene therapy"

3 results found

Sanjeev Gupta, M.D., M.B.,B.S.

Sanjeev Gupta, M.D., M.B.,B.S.

Professor, Medicine (Gastroenterology and Liver Diseases), Einstein

Professor, Pathology, Einstein

The Eleazar and Feige Reicher Chair in Translational Medicine, Einstein

Attending Physician, Medicine, Montefiore Medical Center

Stem cell researchCell therapyGene therapy

Liver diseases

Dr. Gupta is a pioneer in the development of cell therapy – treating disease by introducing healthy cells into the body.  He has discovered various mechanisms for coaxing transplanted cells to attach to host tissue and multiply, paving the way for treating health problems such as  high cholesterol, hemophilia, liver failure, and hepatitis.  read more...

 

Steven K. Libutti, M.D.

Steven K. Libutti, M.D.

Professor and Vice-Chair, Surgery, Einstein and Montefiore Medical Center

Professor, Genetics, Einstein

Director, Montefiore Einstein Center for Cancer Care

Associate Director, Clinical Services, Albert Einstein Cancer Center

Cancer surgeryEndocrine surgeryGene therapy

Dr. Libutti is an expert in surgical oncology and endocrine surgery and a pioneer in tumor targeted gene therapy.  His laboratory studies tumors – particularly those of the pancreas, thyroid and adrenal glands – that trigger the formation of new blood vessels that allow tumors to grow and spread.  A holder of five U.S. patents, he is developing novel cancer therapies by studying the complex interactions that occur within the tumor microenvironment.  read more...

 

Eric E. Bouhassira, Ph.D.

Eric E. Bouhassira, Ph.D.

Professor, Medicine (Hematology)

Professor, Cell Biology

Ingeborg and Ira Leon Rennert Professor of Stem Cell Biology and Regenerative Medicine

Director, Einstein Center for Human Embryonic Stem Cell Research

Stem cell researchBlood-forming stem cellsCell therapy

Dr. Bouhassira’s work focuses on prompting human embryonic stem cells to develop into hematopoietic (blood-forming) stem cells. This work could potentially help patients needing transfusions and save lives by expanding the production of customized cells that could be transplanted without risk of rejection. read more...